tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 173 are a BUY (83.57%), 34 are a HOLD (16.43%).
Analyst Emily Bodnar, carries an average stock price target met ratio of 28.01% that have a potential upside of 51.72% achieved within 84 days. Previously, Emily Bodnar worked at HC WAINWRIGHT.
Emily Bodnar’s has documented 378 price targets and ratings displayed on 23 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on FEMY, Femasys at 28-Mar-2025.
Analyst best performing recommendations are on BCTX (BRIACELL THERAPEUTICS CORP).
The best stock recommendation documented was for NVCR (NOVOCURE LTD) at 11/21/2024. The price target of $30 was fulfilled within 12 days with a profit of $12.91 (75.54%) receiving and performance score of 62.95.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$48
$0.45 (0.95%)
$48
1 years 8 months 16 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
$56
1 years 9 months 30 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$68
1 years 10 months 5 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$38
1 years 10 months 5 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
1 years 10 months 5 days ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
